Biederman: After Me, There is Only God
A series of slides, all prepared by Dr. Biederman–according to his sworn testimony–are revealing as they raise serious doubts about the scientific and ethical integrity of his oeuvre.
Psychiatrists On the Take: the Focus of Government Investigations
Two prominent academic-psychiatrists–Jeffrey Bostic MD, director of school psychiatry, Harvard-Massachusetts General Hospital, and Charles Nemeroff MD, the former chairman of psychiatry at Emory–are featured in current government investigations.
Doctors On the Take May Go to Prison
Like their benefactors–drug manufacturers–who violate the law, doctors will be prosecuted in court by the federal government.
Sen. Grassley to Pfizer: Provide Details of $$ to Harvard MedicalFaculty
Sen. Charles Grassley sent a letter to Pfizer asking the company to provide details of its payments to at least 149 faculty members at Harvard Medical School.
Marcia Angell: Drug Co & Doctors: A Story of Corruption
"It is simply no longer possible to believe much of the clinical research that is published, or to rely on the judgment of trusted physicians or authoritative medical guidelines. I take no pleasure in this conclusion, which I reached slowly and reluctantly over my two decades as an editor of The New England Journal of Medicine." Marcia Angell, MD
Biederman J & J Risperdal Documents
A group of internal emails by Johnson & Johnson officials-mostly from officials in the company’s Risperdal marketing division-provide a bird’s eye view of collusion between the drug giant and Harvard’s leading child psychiatrist, Dr. Joseph Biederman, and one of Harvard’s premier teaching hospitals, Massachusetts General Hospital.
Antipsychotic Use in Children: FDA Panel Rejects FDA Soft-Peddle Approach
"The committee’s concerns are part of a growing chorus of complaints about the increasing use of antipsychotic medicines in children and teenagers.
Vera Sharav: A Profile in Nature Biotechnology
Dr. Marcia Angell, a senior lecturer at Harvard Medical School, and former editor of the New England Journal of Medicine and author of The Truth About Drug Companies, describes Sharav as an extraordinarily observant and valuable critic. "I see her as someone the research establishment badly needs."
Grassley Probes COI at American Psychiatric Association
Sen. Grassley is peeling away psychiatry’s layers of deception about the efficacy and safety of its treatments: "I have come to understand that money from the pharmaceutical industry can shape the practices of nonprofit organizations that purport to be independent in their viewpoints and actions."
Letter of Complaint Re: FDA Double Agent
A follow-up letter to FDA Commissioner, Andrew vonEschenbach RE: Thomas Laughren, FDA’s ‘s Director of Psychiatry Products who has been actively promoting psychotropic drugs–even penning his name to ghostwritten industry-sponsored articles and consensus panels.
Letter of Complaint to FDA Commissioner, 2007
Complaint about a surge of FDA administrative approvals for expanded use of highly toxic antipsychotic drugs for children. Approvals were determined by Dr. Thomas Laughren after secret deliberations–without disclosure of scientific data, without an advisory panel or open public discussion.
Non-profit Fronts for Drug Industry_Boston Globe
These paid lobbying efforts on behalf of industry are carried out under the pretext of advocacy in the public interest.